about
Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirinThromboxane-dependent CD40 ligand release in type 2 diabetes mellitusPlatelet activation in type 2 diabetes mellitusNOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery diseaseVitamin E reduces monocyte tissue factor expression in cirrhotic patientsPortal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.[The prevalence of arrhythmias in subjects over 80 years old. The prognostic role of anamnestic symptomatology and the therapeutic directions]Increased soluble P-selectin levels in hepatitis C virus-related chronic hepatitis: correlation with viral load.[The efficacy of i.v. immunoglobulins at high doses in a case of thrombocytopenia with an immune pathogenesis in chronic lymphocytic leukemia]Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?Antiplatelet therapy in peripheral artery disease.Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction.Enhanced expression of monocyte tissue factor in patients with liver cirrhosis.Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study.Oxidant stress and platelet activation in hypercholesterolemia.Inflammation, insulin resistance, and obesity.Platelet isoprostane overproduction in diabetic patients treated with aspirin.Endothelial dysfunction and oxidative stress in arterial hypertension.Low-density lipoprotein-lowering medication and platelet function.Ageing/Menopausal Status in Healthy Women and Ageing in Healthy Men Differently Affect Cardiometabolic ParametersRelation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver.Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis.CD40/CD40L system and vascular disease.Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosusRole of NADPH oxidase in atherosclerosis.Nutrition, supplements, and vitamins in platelet function and bleeding.Nutraceuticals in the early infancy.Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.Asymptomatic peripheral artery disease and antiplatelet management.Impact of sex and gender on the efficacy of antiplatelet therapy: the female perspective.Rational design, synthesis, and DNA binding properties of novel sequence-selective peptidyl congeners of ametantrone.Leptin increase is associated with markers of the hemostatic system in obese healthy women.Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2.Inflammation and Thrombophilia in Pregnancy Complications: Implications for Risk Assessment and Clinical Management.Treatment and Response to Statins: Gender-related Differences.Chronotype, gender and general health.Kidney disease and venous thromboembolism: Does being woman make the difference?Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study.Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences.
P50
Q28165415-7D1667A9-FA25-4BD5-A95C-ECF41879A50EQ28194498-F6BE7D3D-94C8-437A-993F-A5E7D75150F1Q28210554-57C996D9-93AB-4D30-B383-714190FCE98CQ28259845-54E19C31-82B8-4681-9CFD-D6E03C5D636EQ28374040-5D175F7B-EF41-4946-A379-490E491C299BQ30277075-ADB7CC2E-40A9-49A3-A6A5-BCDDDC97DCD0Q33174506-63035F0C-1BA9-4DB7-8E57-EA9E537B0E51Q33338690-34BB75E4-EFD2-45C9-AD71-63871C5EA2A6Q33361744-5F52F5F9-B8ED-4142-92EE-1E8F04DE4F05Q33396026-EDE0DCCC-409D-4B44-80CA-2EA885386213Q34295685-638A6927-2E72-4120-B0EB-697F4F85CC13Q34320303-A2BC3315-0222-458D-AFB6-3D6818497DDBQ35352128-9633E397-0D74-4077-A80A-C963203C755CQ35640209-A31020E6-8B42-43B4-AD19-02A06A208A63Q35830479-CDBF3B4E-5DD1-4B2F-97A2-4EE014113C1FQ35918777-63177495-4601-40E7-8EF9-10914C496690Q35976574-CEF04F31-2B6E-4C49-8444-D159AE1C4DCAQ36437493-816D2DD5-2427-4EED-9800-94CD24F01F42Q36551327-C4CA6B67-53CE-42FE-8699-ECE3F3167FC1Q36610624-17569C1C-2C28-4EC9-AADB-9D7084BE3B3DQ36886592-E6301AF6-951A-4CBC-BF15-3B6FBF996FBAQ36907331-465B8FE3-3213-4308-99B0-1169E5D2E061Q37017170-43A8FB74-73CA-4164-91A4-78D6B322E3A9Q37111561-33B7305F-A7D6-49AF-A9EA-756B5D5813CDQ37445914-A5D2AA3D-FD15-48F7-8117-5989DB6AC919Q37701160-DD476111-4209-4B94-B289-E481D4341D01Q37765621-B10E2DB5-E3A9-48C2-92F8-30102502647CQ37888519-EC0B2848-1CAD-46AA-8ADF-19B713B52D04Q38242128-7CA744F9-CA66-46F0-9E64-232233167625Q38271138-D396034B-56A7-410C-A9F8-E12280AE81CAQ38344078-818FD08A-D427-4439-8BEF-DFAB7248E667Q38347821-67623674-2D73-485B-8645-A074AF82573CQ38426111-92EEA8E8-EE46-4043-AD75-135818B2B014Q38471149-4A76F9F7-415B-496D-A1A3-E5ADD37E0186Q38684442-54E31149-7A75-4E9B-B4E1-48D179055256Q38759706-E7F8565B-6DEC-48EC-8E04-7297ACA0B68CQ38826365-63D4D527-17E1-4404-9C38-9FD63A061A1BQ38930050-F5AF887C-979A-4950-953A-1602F93D5FA0Q39021448-49CC9588-03B0-4C20-8BC7-0B1408035880Q39023816-8736C638-1B22-4312-86D8-5417B07A97DC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefania Basili
@ast
Stefania Basili
@en
Stefania Basili
@es
Stefania Basili
@nl
Stefania Basili
@sl
type
label
Stefania Basili
@ast
Stefania Basili
@en
Stefania Basili
@es
Stefania Basili
@nl
Stefania Basili
@sl
prefLabel
Stefania Basili
@ast
Stefania Basili
@en
Stefania Basili
@es
Stefania Basili
@nl
Stefania Basili
@sl
P1053
K-4024-2016
P106
P21
P31
P3829
P496
0000-0002-6987-1926